Scarica l'app Stockscreener
2.83
1.43%
0.04
Dopo l'orario di chiusura:
2.83
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ACHV Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.79
Aprire:
$2.79
Volume 24 ore:
1.42M
Relative Volume:
1.17
Capitalizzazione di mercato:
$144.63M
Reddito:
-
Utile/perdita netta:
$-32.94M
Rapporto P/E:
-2.5495
EPS:
-1.11
Flusso di cassa netto:
$-24.95M
1 W Prestazione:
-5.03%
1M Prestazione:
+8.02%
6M Prestazione:
-1.74%
1 anno Prestazione:
-31.97%
Intervallo 1D:
$2.68
$2.87
Intervallo di 1 settimana:
$2.68
$3.1399
Portata 52W:
$1.84
$5.31
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Nome
Achieve Life Sciences Inc
Settore
Industria
Telefono
425-686-1500
Indirizzo
22722 29TH DR. SE, SEATTLE, BC
Confronta ACHV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
2.83 | 142.58M | 0 | -32.94M | -24.95M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-21 | Iniziato | H.C. Wainwright | Buy |
| 2024-11-14 | Iniziato | Rodman & Renshaw | Buy |
| 2024-09-27 | Iniziato | Raymond James | Strong Buy |
| 2023-05-10 | Reiterato | Maxim Group | Buy |
| 2021-06-23 | Iniziato | Oppenheimer | Outperform |
Achieve Life Sciences Inc Borsa (ACHV) Ultime notizie
How institutional ownership impacts Achieve Life Sciences Inc. stockStop Loss & Daily Chart Pattern Signal Reports - Newser
Can trapped investors hope for a rebound in Achieve Life Sciences Inc.Market Growth Summary & Stock Portfolio Risk Control - Newser
News impact scoring models applied to Achieve Life Sciences Inc.IPO Watch & Verified Entry Point Detection - Newser
Comparing Achieve Life Sciences Inc. in custom built stock radars2025 Earnings Impact & Free Technical Pattern Based Buy Signals - Newser
Will Achieve Life Sciences Inc. see short term momentum - Newser
Is Achieve Life Sciences Inc. showing signs of accumulationJuly 2025 Decliners & Short-Term Trading Opportunity Alerts - Newser
Should you wait for a breakout in Achieve Life Sciences Inc.July 2025 Analyst Calls & Real-Time Market Sentiment Reports - Newser
Chart based analysis of Achieve Life Sciences Inc. trendsBull Run & Risk Managed Trade Strategies - Newser
Using portfolio simulators with Achieve Life Sciences Inc. included2025 Breakouts & Breakdowns & Community Shared Stock Ideas - Newser
Smart tools for monitoring Achieve Life Sciences Inc.’s price actionEarnings Risk Summary & Community Verified Watchlist Alerts - Newser
Volume spikes in Achieve Life Sciences Inc. stock – what they meanOptions Play & Real-Time Volume Trigger Notifications - Newser
Achieve Life Sciences shares fall 1.75% premarket after FDA acceptance of cytisinicline NDA for smoking cessation. - AInvest
What is the target price for Achieve Life Sciences Inc. stockBuy Signal & Weekly High Conviction Ideas - خودرو بانک
Order flow analysis tools used on Achieve Life Sciences Inc.Weekly Gains Summary & Weekly Watchlist for Consistent Profits - Newser
Using flow based indicators on Achieve Life Sciences Inc.July 2025 Sentiment & Low Drawdown Momentum Trade Ideas - Newser
Achieve Life Sciences shares rise 1.36% after-hours after FDA acceptance of cytisinicline NDA for smoking cessation. - AInvest
Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation - MarketScreener
FDA accepts Achieve Life Sciences’ NDA for smoking cessation drug - Investing.com
Achieve Life Sciences' nicotine dependence treatment under FDA review - Seeking Alpha
Achieve Life Sciences Says FDA Accepts Marketing Application for Smoking Cessation Drug - MarketScreener
Achieve Life Sciences Announces FDA Acceptance of - GlobeNewswire
First New Smoking Cessation Drug in Two Decades: FDA to Review Achieve's Cytisinicline Treatment - Stock Titan
Nantahala Capital Management LLC Grows Stock Position in Achieve Life Sciences, Inc. $ACHV - MarketBeat
Real time breakdown of Achieve Life Sciences Inc. stock performance2025 Risk Factors & Consistent Growth Equity Picks - Newser
Should you avoid Achieve Life Sciences Inc. stock right nowJuly 2025 Macro Moves & Scalable Portfolio Growth Methods - خودرو بانک
Published on: 2025-09-03 03:38:25 - Newser
Can Achieve Life Sciences Inc. outperform in the next rallyJuly 2025 Big Picture & Expert Verified Stock Movement Alerts - خودرو بانک
Measuring Achieve Life Sciences Inc.’s beta against major indicesJuly 2025 Snapshot & Daily Risk Controlled Trade Plans - Newser
Technical analysis overview for Achieve Life Sciences Inc. stockIPO Watch & Free Weekly Chart Analysis and Trade Guides - Newser
Achieve Life Sciences shares rise 2.05% after-hours as CEO Rick Stewart participates in upcoming conferences. - AInvest
Is Achieve Life Sciences Inc. benefiting from interest rate changesWeekly Profit Recap & Expert Curated Trade Setups - خودرو بانک
Is Achieve Life Sciences Inc. a cyclical or defensive stockTake Profit & Real-Time Buy Signal Notifications - khodrobank.com
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences - GlobeNewswire
Achieve Life Sciences CEO to Present at Two Upcoming Conferences. - AInvest
Smoking Cessation Drug Developer Achieve Life Sciences Featured at Two Major Investment Conferences - Stock Titan
Why Achieve Life Sciences Inc. stock attracts strong analyst attentionMarket Risk Summary & Daily Market Momentum Tracking - Newser
What makes Achieve Life Sciences Inc. stock attractive to long term investorsTrade Risk Report & Risk Adjusted Buy and Sell Alerts - Newser
Is Achieve Life Sciences Inc. in accumulation or distribution phaseJuly 2025 Analyst Calls & Fast Gain Swing Alerts - خودرو بانک
Does Achieve Life Sciences Inc. meet Warren Buffett’s criteriaJuly 2025 Setups & Risk Controlled Swing Trade Alerts - خودرو بانک
Can momentum traders help lift Achieve Life Sciences Inc.Weekly Trend Summary & Safe Capital Growth Plans - Newser
Achieve Life Sciences Inc Azioni (ACHV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):